-
1
-
-
84920837701
-
Cancer statistics, 2015
-
1 [PMID: 25559415]
-
1 Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015; 65: 5-29 [PMID: 25559415 DOI: 10.3322/caac.21254]
-
(2015)
CA Cancer J Clin
, vol.65
, pp. 5-29
-
-
Siegel, RL1
Miller, KD2
Jemal, A.3
-
2
-
-
77949264996
-
Advanced pancreatic carcinoma: current treatment and future challenges
-
2 [PMID: 20101258]
-
2 Stathis A, Moore MJ. Advanced pancreatic carcinoma: current treatment and future challenges. Nat Rev Clin Oncol 2010; 7: 163-172 [PMID: 20101258 DOI: 10.1038/nrclinonc.2009.236]
-
(2010)
Nat Rev Clin Oncol
, vol.7
, pp. 163-172
-
-
Stathis, A1
Moore, MJ.2
-
3
-
-
80053580474
-
Determinants of outcomes in pancreatic surgery and use of hospital resources
-
3 [PMID: 21520092]
-
3 Gupta PK, Turaga KK, Miller WJ, Loggie BW, Foster JM. Determinants of outcomes in pancreatic surgery and use of hospital resources. J Surg Oncol 2011; 104: 634-640 [PMID: 21520092 DOI: 10.1002/jso.21923]
-
(2011)
J Surg Oncol
, vol.104
, pp. 634-640
-
-
Gupta, PK1
Turaga, KK2
Miller, WJ3
Loggie, BW4
Foster, JM.5
-
4
-
-
84903140829
-
Imaging diagnosis of pancreatic cancer: a state-of-the-art review
-
4 [PMID: 24976723]
-
4 Lee ES, Lee JM. Imaging diagnosis of pancreatic cancer: a state-of-the-art review. World J Gastroenterol 2014; 20: 7864-7877 [PMID: 24976723 DOI: 10.3748/wjg.v20.i24.7864]
-
(2014)
World J Gastroenterol
, vol.20
, pp. 7864-7877
-
-
Lee, ES1
Lee, JM.2
-
5
-
-
79955921754
-
FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer
-
5 [PMID: 21561347]
-
5 Conroy T, Desseigne F, Ychou M, Bouche O, Guimbaud R, Becouarn Y, Adenis A, Raoul JL, Gourgou-Bourgade S, de la Fouchardiere C, Bennouna J, Bachet JB, Khemissa-Akouz F, Pere-Verge D, Delbaldo C, Assenat E, Chauffert B, Michel P, Montoto-Grillot C, Ducreux M. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 2011; 364: 1817-1825 [PMID: 21561347 DOI: 10.1056/NEJMoa1011923]
-
(2011)
N Engl J Med
, vol.364
, pp. 1817-1825
-
-
Conroy, T1
Desseigne, F2
Ychou, M3
Bouche, O4
Guimbaud, R5
Becouarn, Y6
Adenis, A7
Raoul, JL8
Gourgou-Bourgade, S9
de la Fouchardiere, C10
Bennouna, J11
Bachet, JB12
Khemissa-Akouz, F13
Pere-Verge, D14
Delbaldo, C15
Assenat, E16
Chauffert, B17
Michel, P18
Montoto-Grillot, C19
Ducreux, M.20
more..
-
6
-
-
84886741654
-
Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine
-
6 [PMID: 24131140]
-
6 Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, Moore M, Seay T, Tjulandin SA, Ma WW, Saleh MN, Harris M, Reni M, Dowden S, Laheru D, Bahary N, Ramanathan RK, Tabernero J, Hidalgo M, Goldstein D, Van Cutsem E, Wei X, Iglesias J, Renschler MF. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med 2013; 369: 1691-1703 [PMID: 24131140 DOI: 10.1056/NEJMoa1304369]
-
(2013)
N Engl J Med
, vol.369
, pp. 1691-1703
-
-
Von Hoff, DD1
Ervin, T2
Arena, FP3
Chiorean, EG4
Infante, J5
Moore, M6
Seay, T7
Tjulandin, SA8
Ma, WW9
Saleh, MN10
Harris, M11
Reni, M12
Dowden, S13
Laheru, D14
Bahary, N15
Ramanathan, RK16
Tabernero, J17
Hidalgo, M18
Goldstein, D19
Van Cutsem, E20
Wei, X21
Iglesias, J22
Renschler, MF.23
more..
-
7
-
-
84905011409
-
Pancreaticoduodenectomy with vascular resection for pancreatic head adenocarcinoma
-
7 [PMID: 24833085]
-
7 Liles JS, Katz MH. Pancreaticoduodenectomy with vascular resection for pancreatic head adenocarcinoma. Expert Rev Anticancer Ther 2014; 14: 919-929 [PMID: 24833085 DOI: 10.158 6/14737140.2014.919860]
-
(2014)
Expert Rev Anticancer Ther
, vol.14
, pp. 919-929
-
-
Liles, JS1
Katz, MH.2
-
8
-
-
84895889311
-
Management of borderline resectable pancreatic cancer
-
8 [PMID: 24635867]
-
8 Katz MH, Crane CH, Varadhachary G. Management of borderline resectable pancreatic cancer. Semin Radiat Oncol 2014; 24: 105-112 [PMID: 24635867 DOI: 10.1016/j.semradonc.2013.11.006]
-
(2014)
Semin Radiat Oncol
, vol.24
, pp. 105-112
-
-
Katz, MH1
Crane, CH2
Varadhachary, G.3
-
9
-
-
57149111282
-
Staging of pancreatic adenocarcinoma by imaging studies
-
9 [PMID: 18948228]
-
9 Wong JC, Lu DS. Staging of pancreatic adenocarcinoma by imaging studies. Clin Gastroenterol Hepatol 2008; 6: 1301-1308 [PMID: 18948228 DOI: 10.1016/j.cgh.2008.09.014]
-
(2008)
Clin Gastroenterol Hepatol
, vol.6
, pp. 1301-1308
-
-
Wong, JC1
Lu, DS.2
-
10
-
-
50049093501
-
PET/CT fusion scan enhances CT staging in patients with pancreatic neoplasms
-
10 [PMID: 18551347]
-
10 Farma JM, Santillan AA, Melis M, Walters J, Belinc D, Chen DT, Eikman EA, Malafa M. PET/CT fusion scan enhances CT staging in patients with pancreatic neoplasms. Ann Surg Oncol 2008; 15: 2465-2471 [PMID: 18551347 DOI: 10.1245/s10434-008-9992-0]
-
(2008)
Ann Surg Oncol
, vol.15
, pp. 2465-2471
-
-
Farma, JM1
Santillan, AA2
Melis, M3
Walters, J4
Belinc, D5
Chen, DT6
Eikman, EA7
Malafa, M.8
-
11
-
-
84901491136
-
Usefulness of F-18-fluorodeoxyglucose positron emission tomography to confirm suspected pancreatic cancer: a meta-analysis
-
11 [PMID: 24755095]
-
11 Rijkers AP, Valkema R, Duivenvoorden HJ, van Eijck CH. Usefulness of F-18-fluorodeoxyglucose positron emission tomography to confirm suspected pancreatic cancer: a meta-analysis. Eur J Surg Oncol 2014; 40: 794-804 [PMID: 24755095 DOI: 10.1016/j.ejso.2014.03.016]
-
(2014)
Eur J Surg Oncol
, vol.40
, pp. 794-804
-
-
Rijkers, AP1
Valkema, R2
Duivenvoorden, HJ3
van Eijck, CH.4
-
12
-
-
2942679618
-
Endoscopic ultrasound-guided fine needle aspiration and multidetector spiral CT in the diagnosis of pancreatic cancer
-
12 [PMID: 15128348]
-
12 Agarwal B, Abu-Hamda E, Molke KL, Correa AM, Ho L. Endoscopic ultrasound-guided fine needle aspiration and multidetector spiral CT in the diagnosis of pancreatic cancer. Am J Gastroenterol 2004; 99: 844-850 [PMID: 15128348 DOI: 10.1111/ j.1572-0241.2004.04177.x]
-
(2004)
Am J Gastroenterol
, vol.99
, pp. 844-850
-
-
Agarwal, B1
Abu-Hamda, E2
Molke, KL3
Correa, AM4
Ho, L.5
-
13
-
-
0030831942
-
The clinical utility of endoscopic ultrasound-guided fine-needle aspiration in the diagnosis and staging of pancreatic carcinoma
-
13 [PMID: 9165320]
-
13 Chang KJ, Nguyen P, Erickson RA, Durbin TE, Katz KD. The clinical utility of endoscopic ultrasound-guided fine-needle aspiration in the diagnosis and staging of pancreatic carcinoma. Gastrointest Endosc 1997; 45: 387-393 [PMID: 9165320]
-
(1997)
Gastrointest Endosc
, vol.45
, pp. 387-393
-
-
Chang, KJ1
Nguyen, P2
Erickson, RA3
Durbin, TE4
Katz, KD.5
-
14
-
-
84878529692
-
Randomized trial comparing fanning with standard technique for endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic mass lesions
-
14 [PMID: 23504490]
-
14 Bang JY, Magee SH, Ramesh J, Trevino JM, Varadarajulu S. Randomized trial comparing fanning with standard technique for endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic mass lesions. Endoscopy 2013; 45: 445-450 [PMID: 23504490 DOI: 10.1055/s-0032-1326268]
-
(2013)
Endoscopy
, vol.45
, pp. 445-450
-
-
Bang, JY1
Magee, SH2
Ramesh, J3
Trevino, JM4
Varadarajulu, S.5
-
15
-
-
77957122878
-
The role of laparoscopy and laparoscopic ultrasound in the preoperative staging of pancreatico-biliary cancers—A metaanalysis
-
15 [PMID: 20547445]
-
15 Hariharan D, Constantinides VA, Froeling FE, Tekkis PP, Kocher HM. The role of laparoscopy and laparoscopic ultrasound in the preoperative staging of pancreatico-biliary cancers—A metaanalysis. Eur J Surg Oncol 2010; 36: 941-948 [PMID: 20547445 DOI: 10.1016/j.ejso.2010.05.015]
-
(2010)
Eur J Surg Oncol
, vol.36
, pp. 941-948
-
-
Hariharan, D1
Constantinides, VA2
Froeling, FE3
Tekkis, PP4
Kocher, HM.5
-
16
-
-
84890701293
-
Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the society of abdominal radiology and the american pancreatic association
-
16 e1 [PMID: 24355035]
-
16 Al-Hawary MM, Francis IR, Chari ST, Fishman EK, Hough DM, Lu DS, Macari M, Megibow AJ, Miller FH, Mortele KJ, Merchant NB, Minter RM, Tamm EP, Sahani DV, Simeone DM. Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the society of abdominal radiology and the american pancreatic association. Gastroenterology 2014; 146: 291-304.e1 [PMID: 24355035 DOI: 10.1053/j.gastro.2013.11.004]
-
(2014)
Gastroenterology
, vol.146
, pp. 291-304
-
-
Al-Hawary, MM1
Francis, IR2
Chari, ST3
Fishman, EK4
Hough, DM5
Lu, DS6
Macari, M7
Megibow, AJ8
Miller, FH9
Mortele, KJ10
Merchant, NB11
Minter, RM12
Tamm, EP13
Sahani, DV14
Simeone, DM.15
-
17
-
-
84880252981
-
Borderline resectable pancreatic cancer: need for standardization and methods for optimal clinical trial design
-
17 [PMID: 23435609]
-
17 Katz MH, Marsh R, Herman JM, Shi Q, Collison E, Venook AP, Kindler HL, Alberts SR, Philip P, Lowy AM, Pisters PW, Posner MC, Berlin JD, Ahmad SA. Borderline resectable pancreatic cancer: need for standardization and methods for optimal clinical trial design. Ann Surg Oncol 2013; 20: 2787-2795 [PMID: 23435609 DOI: 10.1245/s10434-013-2886-9]
-
(2013)
Ann Surg Oncol
, vol.20
, pp. 2787-2795
-
-
Katz, MH1
Marsh, R2
Herman, JM3
Shi, Q4
Collison, E5
Venook, AP6
Kindler, HL7
Alberts, SR8
Philip, P9
Lowy, AM10
Pisters, PW11
Posner, MC12
Berlin, JD13
Ahmad, SA.14
-
18
-
-
33748365398
-
Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy
-
18 [PMID: 16865597]
-
18 Varadhachary GR, Tamm EP, Abbruzzese JL, Xiong HQ, Crane CH, Wang H, Lee JE, Pisters PW, Evans DB, Wolff RA. Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol 2006; 13: 1035-1046 [PMID: 16865597 DOI: 10.1245/ASO.2006.08.011]
-
(2006)
Ann Surg Oncol
, vol.13
, pp. 1035-1046
-
-
Varadhachary, GR1
Tamm, EP2
Abbruzzese, JL3
Xiong, HQ4
Crane, CH5
Wang, H6
Lee, JE7
Pisters, PW8
Evans, DB9
Wolff, RA.10
-
19
-
-
33745064860
-
Systematic review of outcome of synchronous portal-superior mesenteric vein resection during pancreatectomy for cancer
-
19 [PMID: 16703621]
-
19 Siriwardana HP, Siriwardena AK. Systematic review of outcome of synchronous portal-superior mesenteric vein resection during pancreatectomy for cancer. Br J Surg 2006; 93: 662-673 [PMID: 16703621 DOI: 10.1002/bjs.5368]
-
(2006)
Br J Surg
, vol.93
, pp. 662-673
-
-
Siriwardana, HP1
Siriwardena, AK.2
-
20
-
-
33751505341
-
Results of vascular resections during pancreatectomy from two European centres: an analysis of survival and disease-free survival explicative factors
-
20 [PMID: 18333103]
-
20 Adham M, Mirza DF, Chapuis F, Mayer AD, Bramhall SR, Coldham C, Baulieux J, Buckels J. Results of vascular resections during pancreatectomy from two European centres: an analysis of survival and disease-free survival explicative factors. HPB (Oxford) 2006; 8: 465-473 [PMID: 18333103 DOI: 10.1080/1365182060083 9944]
-
(2006)
HPB (Oxford)
, vol.8
, pp. 465-473
-
-
Adham, M1
Mirza, DF2
Chapuis, F3
Mayer, AD4
Bramhall, SR5
Coldham, C6
Baulieux, J7
Buckels, J.8
-
21
-
-
67649213568
-
Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement
-
21 [PMID: 19390900]
-
21 Abrams RA, Lowy AM, O’Reilly EM, Wolff RA, Picozzi VJ, Pisters PW. Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol 2009; 16: 1751-1756 [PMID: 19390900 DOI: 10.1245/s10434-009-0413-9]
-
(2009)
Ann Surg Oncol
, vol.16
, pp. 1751-1756
-
-
Abrams, RA1
Lowy, AM2
O’Reilly, EM3
Wolff, RA4
Picozzi, VJ5
Pisters, PW.6
-
22
-
-
67649207663
-
Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement
-
22 [PMID: 19396496]
-
22 Callery MP, Chang KJ, Fishman EK, Talamonti MS, William Traverso L, Linehan DC. Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement. Ann Surg Oncol 2009; 16: 1727-1733 [PMID: 19396496 DOI: 10.1245/s10434-009-0408-6]
-
(2009)
Ann Surg Oncol
, vol.16
, pp. 1727-1733
-
-
Callery, MP1
Chang, KJ2
Fishman, EK3
Talamonti, MS4
William Traverso, L5
Linehan, DC.6
-
23
-
-
44449085904
-
Results of a pancreatectomy with a limited venous resection for pancreatic cancer
-
23 [PMID: 18516531]
-
23 Illuminati G, Carboni F, Lorusso R, D’Urso A, Ceccanei G, Papaspyropoulos V, Pacile MA, Santoro E. Results of a pancreatectomy with a limited venous resection for pancreatic cancer. Surg Today 2008; 38: 517-523 [PMID: 18516531 DOI: 10.1007/s00595-007-3661-y]
-
(2008)
Surg Today
, vol.38
, pp. 517-523
-
-
Illuminati, G1
Carboni, F2
Lorusso, R3
D’Urso, A4
Ceccanei, G5
Papaspyropoulos, V6
Pacile, MA7
Santoro, E.8
-
24
-
-
33847106918
-
Significance of the depth of portal vein wall invasion after curative resection for pancreatic adenocarcinoma
-
24 ; discussion 180 [PMID: 17309969]
-
24 Fukuda S, Oussoultzoglou E, Bachellier P, Rosso E, Nakano H, Audet M, Jaeck D. Significance of the depth of portal vein wall invasion after curative resection for pancreatic adenocarcinoma. Arch Surg 2007; 142: 172-179; discussion 180 [PMID: 17309969 DOI: 10.1001/archsurg.142.2.172]
-
(2007)
Arch Surg
, vol.142
, pp. 172-179
-
-
Fukuda, S1
Oussoultzoglou, E2
Bachellier, P3
Rosso, E4
Nakano, H5
Audet, M6
Jaeck, D.7
-
25
-
-
84863724498
-
Pancreatectomy combined with superior mesenteric vein-portal vein resection for pancreatic cancer: a meta-analysis
-
25 [PMID: 22350478]
-
25 Zhou Y, Zhang Z, Liu Y, Li B, Xu D. Pancreatectomy combined with superior mesenteric vein-portal vein resection for pancreatic cancer: a meta-analysis. World J Surg 2012; 36: 884-891 [PMID: 22350478 DOI: 10.1007/s00268-012-1461-z]
-
(2012)
World J Surg
, vol.36
, pp. 884-891
-
-
Zhou, Y1
Zhang, Z2
Liu, Y3
Li, B4
Xu, D.5
-
26
-
-
84876490981
-
The impact of vascular resection on early postoperative outcomes after pancreaticoduodenectomy: an analysis of the American Collegeof Surgeons National Surgical Quality Improvement Program database
-
26 [PMID: 22932857]
-
26 Castleberry AW, White RR, De La Fuente SG, Clary BM, Blazer DG, McCann RL, Pappas TN, Tyler DS, Scarborough JE. The impact of vascular resection on early postoperative outcomes after pancreaticoduodenectomy: an analysis of the American Collegeof Surgeons National Surgical Quality Improvement Program database. Ann Surg Oncol 2012; 19: 4068-4077 [PMID: 22932857 DOI: 10.1245/s10434-012-2585-y]
-
(2012)
Ann Surg Oncol
, vol.19
, pp. 4068-4077
-
-
Castleberry, AW1
White, RR2
De La Fuente, SG3
Clary, BM4
Blazer, DG5
McCann, RL6
Pappas, TN7
Tyler, DS8
Scarborough, JE.9
-
27
-
-
84876782328
-
Concomitant vascular reconstruction during pancreatectomy for malignant disease: a propensity score-adjusted, population-based trend analysis involving 10,206 patients
-
27 [PMID: 23715922]
-
27 Worni M, Castleberry AW, Clary BM, Gloor B, Carvalho E, Jacobs DO, Pietrobon R, Scarborough JE, White RR. Concomitant vascular reconstruction during pancreatectomy for malignant disease: a propensity score-adjusted, population-based trend analysis involving 10,206 patients. JAMA Surg 2013; 148: 331-338 [PMID: 23715922 DOI: 10.1001/jamasurg.2013.1058]
-
(2013)
JAMA Surg
, vol.148
, pp. 331-338
-
-
Worni, M1
Castleberry, AW2
Clary, BM3
Gloor, B4
Carvalho, E5
Jacobs, DO6
Pietrobon, R7
Scarborough, JE8
White, RR.9
-
28
-
-
61549102790
-
Arterial and venous resection for pancreatic adenocarcinoma: operative and long-term outcomes
-
28 [PMID: 19221327]
-
28 Martin RC, Scoggins CR, Egnatashvili V, Staley CA, McMasters KM, Kooby DA. Arterial and venous resection for pancreatic adenocarcinoma: operative and long-term outcomes. Arch Surg 2009; 144: 154-159 [PMID: 19221327 DOI: 10.1001/archsurg.2008.547]
-
(2009)
Arch Surg
, vol.144
, pp. 154-159
-
-
Martin, RC1
Scoggins, CR2
Egnatashvili, V3
Staley, CA4
McMasters, KM5
Kooby, DA.6
-
29
-
-
78650671112
-
Is the need for an arterial resection a contraindication to pancreatic resection for locally advanced pancreatic adenocarcinoma? A case-matched controlled study
-
29 [PMID: 21105000]
-
29 Bachellier P, Rosso E, Lucescu I, Oussoultzoglou E, Tracey J, Pessaux P, Ferreira N, Jaeck D. Is the need for an arterial resection a contraindication to pancreatic resection for locally advanced pancreatic adenocarcinoma? A case-matched controlled study. J Surg Oncol 2011; 103: 75-84 [PMID: 21105000 DOI: 10.1002/ jso.21769]
-
(2011)
J Surg Oncol
, vol.103
, pp. 75-84
-
-
Bachellier, P1
Rosso, E2
Lucescu, I3
Oussoultzoglou, E4
Tracey, J5
Pessaux, P6
Ferreira, N7
Jaeck, D.8
-
30
-
-
81855198904
-
Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis
-
30 [PMID: 22064622]
-
30 Mollberg N, Rahbari NN, Koch M, Hartwig W, Hoeger Y, Buchler MW, Weitz J. Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis. Ann Surg 2011; 254: 882-893 [PMID: 22064622 DOI: 10.1097/ SLA.0b013e31823ac299]
-
(2011)
Ann Surg
, vol.254
, pp. 882-893
-
-
Mollberg, N1
Rahbari, NN2
Koch, M3
Hartwig, W4
Hoeger, Y5
Buchler, MW6
Weitz, J.7
-
31
-
-
79952677716
-
Vascular reconstruction during pancreatoduodenectomy for ductal adenocarcinoma of the pancreas improves resectability but does not achieve cure
-
31 [PMID: 20607257]
-
31 Ouaissi M, Hubert C, Verhelst R, Astarci P, Sempoux C, Jouret-Mourin A, Loundou A, Gigot JF. Vascular reconstruction during pancreatoduodenectomy for ductal adenocarcinoma of the pancreas improves resectability but does not achieve cure. World J Surg 2010; 34: 2648-2661 [PMID: 20607257 DOI: 10.1007/ s00268-010-0699-6]
-
(2010)
World J Surg
, vol.34
, pp. 2648-2661
-
-
Ouaissi, M1
Hubert, C2
Verhelst, R3
Astarci, P4
Sempoux, C5
Jouret-Mourin, A6
Loundou, A7
Gigot, JF.8
-
32
-
-
78650134687
-
Arterial en bloc resection for pancreatic carcinoma
-
32 [PMID: 21136564]
-
32 Bockhorn M, Burdelski C, Bogoevski D, Sgourakis G, Yekebas EF, Izbicki JR. Arterial en bloc resection for pancreatic carcinoma. Br J Surg 2011; 98: 86-92 [PMID: 21136564 DOI: 10.1002/bjs.7270]
-
(2011)
Br J Surg
, vol.98
, pp. 86-92
-
-
Bockhorn, M1
Burdelski, C2
Bogoevski, D3
Sgourakis, G4
Yekebas, EF5
Izbicki, JR.6
-
33
-
-
84898851128
-
Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival
-
33 [PMID: 24473642]
-
33 Rose JB, Rocha FG, Alseidi A, Biehl T, Moonka R, Ryan JA, Lin B, Picozzi V, Helton S. Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival. Ann Surg Oncol 2014; 21: 1530-1537 [PMID: 24473642 DOI: 10.1245/s10434-014-3486-z]
-
(2014)
Ann Surg Oncol
, vol.21
, pp. 1530-1537
-
-
Rose, JB1
Rocha, FG2
Alseidi, A3
Biehl, T4
Moonka, R5
Ryan, JA6
Lin, B7
Picozzi, V8
Helton, S.9
-
34
-
-
0031056942
-
Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas
-
34 [PMID: 9060530]
-
34 Spitz FR, Abbruzzese JL, Lee JE, Pisters PW, Lowy AM, Fenoglio CJ, Cleary KR, Janjan NA, Goswitz MS, Rich TA, Evans DB. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol 1997; 15: 928-937 [PMID: 9060530]
-
(1997)
J Clin Oncol
, vol.15
, pp. 928-937
-
-
Spitz, FR1
Abbruzzese, JL2
Lee, JE3
Pisters, PW4
Lowy, AM5
Fenoglio, CJ6
Cleary, KR7
Janjan, NA8
Goswitz, MS9
Rich, TA10
Evans, DB.11
-
35
-
-
0035093234
-
Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration
-
35 [PMID: 11258776]
-
35 Breslin TM, Hess KR, Harbison DB, Jean ME, Cleary KR, Dackiw AP, Wolff RA, Abbruzzese JL, Janjan NA, Crane CH, Vauthey JN, Lee JE, Pisters PW, Evans DB. Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. Ann Surg Oncol 2001; 8: 123-132 [PMID: 11258776]
-
(2001)
Ann Surg Oncol
, vol.8
, pp. 123-132
-
-
Breslin, TM1
Hess, KR2
Harbison, DB3
Jean, ME4
Cleary, KR5
Dackiw, AP6
Wolff, RA7
Abbruzzese, JL8
Janjan, NA9
Crane, CH10
Vauthey, JN11
Lee, JE12
Pisters, PW13
Evans, DB.14
-
36
-
-
84925496322
-
Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic cancer
-
36 [PMID: 25352267]
-
36 Roland CL, Yang AD, Katz MH, Chatterjee D, Wang H, Lin H, Vauthey JN, Pisters PW, Varadhachary GR, Wolff RA, Crane CH, Lee JE, Fleming JB. Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic cancer. Ann Surg Oncol 2015; 22: 1168-1175 [PMID: 25352267 DOI: 10.1245/s10434-014-4192-6]
-
(2015)
Ann Surg Oncol
, vol.22
, pp. 1168-1175
-
-
Roland, CL1
Yang, AD2
Katz, MH3
Chatterjee, D4
Wang, H5
Lin, H6
Vauthey, JN7
Pisters, PW8
Varadhachary, GR9
Wolff, RA10
Crane, CH11
Lee, JE12
Fleming, JB.13
-
37
-
-
84869491833
-
Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators
-
37 [PMID: 22605518]
-
37 Katz MH, Fleming JB, Bhosale P, Varadhachary G, Lee JE, Wolff R, Wang H, Abbruzzese J, Pisters PW, Vauthey JN, Charnsangavej C, Tamm E, Crane CH, Balachandran A. Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators. Cancer 2012; 118: 5749-5756 [PMID: 22605518 DOI: 10.1002/cncr.27636]
-
(2012)
Cancer
, vol.118
, pp. 5749-5756
-
-
Katz, MH1
Fleming, JB2
Bhosale, P3
Varadhachary, G4
Lee, JE5
Wolff, R6
Wang, H7
Abbruzzese, J8
Pisters, PW9
Vauthey, JN10
Charnsangavej, C11
Tamm, E12
Crane, CH13
Balachandran, A.14
-
38
-
-
84865147618
-
Defined clinical classifications are associated with outcome of patients with anatomically resectable pancreatic adenocarcinoma treated with neoadjuvant therapy
-
38 [PMID: 22258816]
-
38 Tzeng CW, Fleming JB, Lee JE, Xiao L, Pisters PW, Vauthey JN, Abdalla EK, Wolff RA, Varadhachary GR, Fogelman DR, Crane CH, Balachandran A, Katz MH. Defined clinical classifications are associated with outcome of patients with anatomically resectable pancreatic adenocarcinoma treated with neoadjuvant therapy. Ann Surg Oncol 2012; 19: 2045-2053 [PMID: 22258816 DOI: 10.1245/ s10434-011-2211-4]
-
(2012)
Ann Surg Oncol
, vol.19
, pp. 2045-2053
-
-
Tzeng, CW1
Fleming, JB2
Lee, JE3
Xiao, L4
Pisters, PW5
Vauthey, JN6
Abdalla, EK7
Wolff, RA8
Varadhachary, GR9
Fogelman, DR10
Crane, CH11
Balachandran, A12
Katz, MH.13
-
39
-
-
77952028206
-
Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5-fluorouracil, and cisplatin followed by radiotherapy and 5-fluorouracil forpatients with locally advanced, potentially resectable pancreatic adenocarcinoma
-
39 [PMID: 20461765]
-
39 Landry J, Catalano PJ, Staley C, Harris W, Hoffman J, Talamonti M, Xu N, Cooper H, Benson AB. Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5-fluorouracil, and cisplatin followed by radiotherapy and 5-fluorouracil forpatients with locally advanced, potentially resectable pancreatic adenocarcinoma. J Surg Oncol 2010; 101: 587-592 [PMID: 20461765 DOI: 10.1002/jso.21527]
-
(2010)
J Surg Oncol
, vol.101
, pp. 587-592
-
-
Landry, J1
Catalano, PJ2
Staley, C3
Harris, W4
Hoffman, J5
Talamonti, M6
Xu, N7
Cooper, H8
Benson, AB.9
-
40
-
-
43049106807
-
Borderline resectable pancreatic cancer: the importance of this emerging stage of disease
-
40 ; discussion 846-848 [PMID: 18471707]
-
40 Katz MH, Pisters PW, Evans DB, Sun CC, Lee JE, Fleming JB, Vauthey JN, Abdalla EK, Crane CH, Wolff RA, Varadhachary GR, Hwang RF. Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. J Am Coll Surg 2008; 206: 833-846; discussion 846-848 [PMID: 18471707 DOI: 10.1016/ j.jamcollsurg.2007.12.020]
-
(2008)
J Am Coll Surg
, vol.206
, pp. 833-846
-
-
Katz, MH1
Pisters, PW2
Evans, DB3
Sun, CC4
Lee, JE5
Fleming, JB6
Vauthey, JN7
Abdalla, EK8
Crane, CH9
Wolff, RA10
Varadhachary, GR11
Hwang, RF.12
-
41
-
-
79955739621
-
Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer
-
41 [PMID: 21213060]
-
41 Stokes JB, Nolan NJ, Stelow EB, Walters DM, Weiss GR, de Lange EE, Rich TA, Adams RB, Bauer TW. Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer. Ann Surg Oncol 2011; 18: 619-627 [PMID: 21213060 DOI: 10.1245/ s10434-010-1456-7]
-
(2011)
Ann Surg Oncol
, vol.18
, pp. 619-627
-
-
Stokes, JB1
Nolan, NJ2
Stelow, EB3
Walters, DM4
Weiss, GR5
de Lange, EE6
Rich, TA7
Adams, RB8
Bauer, TW.9
-
42
-
-
84880573171
-
A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer
-
42 [PMID: 23720019]
-
42 Kim EJ, Ben-Josef E, Herman JM, Bekaii-Saab T, Dawson LA, Griffith KA, Francis IR, Greenson JK, Simeone DM, Lawrence TS, Laheru D, Wolfgang CL, Williams T, Bloomston M, Moore MJ, Wei A, Zalupski MM. A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer. Cancer 2013; 119: 2692-2700 [PMID: 23720019 DOI: 10.1002/cncr.28117]
-
(2013)
Cancer
, vol.119
, pp. 2692-2700
-
-
Kim, EJ1
Ben-Josef, E2
Herman, JM3
Bekaii-Saab, T4
Dawson, LA5
Griffith, KA6
Francis, IR7
Greenson, JK8
Simeone, DM9
Lawrence, TS10
Laheru, D11
Wolfgang, CL12
Williams, T13
Bloomston, M14
Moore, MJ15
Wei, A16
Zalupski, MM.17
-
43
-
-
84886100191
-
Neoadjuvant chemotherapy with gemcitabine and S-1 for resectable and borderline pancreatic ductal adenocarcinoma: results from a prospective multi-institutional phase 2 trial
-
43 [PMID: 23838925]
-
43 Motoi F, Ishida K, Fujishima F, Ottomo S, Oikawa M, Okada T, Shimamura H, Takemura S, Ono F, Akada M, Nakagawa K, Katayose Y, Egawa S, Unno M. Neoadjuvant chemotherapy with gemcitabine and S-1 for resectable and borderline pancreatic ductal adenocarcinoma: results from a prospective multi-institutional phase 2 trial. Ann Surg Oncol 2013; 20: 3794-3801 [PMID: 23838925 DOI: 10.1245/s10434-013-3129-9]
-
(2013)
Ann Surg Oncol
, vol.20
, pp. 3794-3801
-
-
Motoi, F1
Ishida, K2
Fujishima, F3
Ottomo, S4
Oikawa, M5
Okada, T6
Shimamura, H7
Takemura, S8
Ono, F9
Akada, M10
Nakagawa, K11
Katayose, Y12
Egawa, S13
Unno, M.14
-
44
-
-
84867580625
-
Prospective efficacy and safety study of neoadjuvant gemcitabine with capecitabine combination chemotherapy for borderline-resectable or unresectable locally advanced pancreatic adenocarcinoma
-
44 [PMID: 22682078]
-
44 Lee JL, Kim SC, Kim JH, Lee SS, Kim TW, Park do H, Seo DW, Lee SK, Kim MH, Kim JH, Park JH, Shin SH, Han DJ. Prospective efficacy and safety study of neoadjuvant gemcitabine with capecitabine combination chemotherapy for borderline-resectable or unresectable locally advanced pancreatic adenocarcinoma. Surgery 2012; 152: 851-862 [PMID: 22682078 DOI: 10.1016/ j.surg.2012.03.010]
-
(2012)
Surgery
, vol.152
, pp. 851-862
-
-
Lee, JL1
Kim, SC2
Kim, JH3
Lee, SS4
Kim, TW5
Park do, H6
Seo, DW7
Lee, SK8
Kim, MH9
Kim, JH10
Park, JH11
Shin, SH12
Han, DJ.13
-
45
-
-
84930893148
-
Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma
-
45 [PMID: 25734581]
-
45 Mellon EA, Hoffe SE, Springett GM, Frakes JM, Strom TJ, Hodul PJ, Malafa MP, Chuong MD, Shridhar R. Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma. Acta Oncol 2015; 54: 979-985 [PMID: 25734581 DOI: 10.3109/0284186X.2015.1004367]
-
(2015)
Acta Oncol
, vol.54
, pp. 979-985
-
-
Mellon, EA1
Hoffe, SE2
Springett, GM3
Frakes, JM4
Strom, TJ5
Hodul, PJ6
Malafa, MP7
Chuong, MD8
Shridhar, R.9
-
46
-
-
84888129647
-
Preoperative gemcitabine-based chemoradiation therapy for resectable and borderline resectable pancreatic cancer
-
46 [PMID: 23799421]
-
46 Takahashi H, Ohigashi H, Gotoh K, Marubashi S, Yamada T, Murata M, Ioka T, Uehara H, Yano M, Ishikawa O. Preoperative gemcitabine-based chemoradiation therapy for resectable and borderline resectable pancreatic cancer. Ann Surg 2013; 258: 1040-1050 [PMID: 23799421 DOI: 10.1097/SLA.0b013e31829b3ce4]
-
(2013)
Ann Surg
, vol.258
, pp. 1040-1050
-
-
Takahashi, H1
Ohigashi, H2
Gotoh, K3
Marubashi, S4
Yamada, T5
Murata, M6
Ioka, T7
Uehara, H8
Yano, M9
Ishikawa, O.10
-
47
-
-
49049101358
-
Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head
-
47 [PMID: 18640930]
-
47 Evans DB, Varadhachary GR, Crane CH, Sun CC, Lee JE, Pisters PW, Vauthey JN, Wang H, Cleary KR, Staerkel GA, Charnsangavej C, Lano EA, Ho L, Lenzi R, Abbruzzese JL, Wolff RA. Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. J Clin Oncol 2008; 26: 3496-3502 [PMID: 18640930 DOI: 10.1200/JCO.2007.15.8634]
-
(2008)
J Clin Oncol
, vol.26
, pp. 3496-3502
-
-
Evans, DB1
Varadhachary, GR2
Crane, CH3
Sun, CC4
Lee, JE5
Pisters, PW6
Vauthey, JN7
Wang, H8
Cleary, KR9
Staerkel, GA10
Charnsangavej, C11
Lano, EA12
Ho, L13
Lenzi, R14
Abbruzzese, JL15
Wolff, RA.16
-
48
-
-
49049102131
-
Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head
-
48 [PMID: 18640929]
-
48 Varadhachary GR, Wolff RA, Crane CH, Sun CC, Lee JE, Pisters PW, Vauthey JN, Abdalla E, Wang H, Staerkel GA, Lee JH, Ross WA, Tamm EP, Bhosale PR, Krishnan S, Das P, Ho L, Xiong H, Abbruzzese JL, Evans DB. Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. J Clin Oncol 2008; 26: 3487-3495 [PMID: 18640929 DOI: 10.1200/JCO.2007.15.8642]
-
(2008)
J Clin Oncol
, vol.26
, pp. 3487-3495
-
-
Varadhachary, GR1
Wolff, RA2
Crane, CH3
Sun, CC4
Lee, JE5
Pisters, PW6
Vauthey, JN7
Abdalla, E8
Wang, H9
Staerkel, GA10
Lee, JH11
Ross, WA12
Tamm, EP13
Bhosale, PR14
Krishnan, S15
Das, P16
Ho, L17
Xiong, H18
Abbruzzese, JL19
Evans, DB.20
more..
-
49
-
-
84922538202
-
Neoadjuvant gemcitabine-based accelerated hyperfractionation chemoradiotherapy for patients with borderline resectable pancreatic adenocarcinoma
-
49 [PMID: 25425728]
-
49 Takeda Y, Nakamori S, Eguchi H, Kobayashi S, Marubashi S, Tanemura M, Konishi K, Yoshioka Y, Umeshita K, Mori M, Doki Y, Nagano H. Neoadjuvant gemcitabine-based accelerated hyperfractionation chemoradiotherapy for patients with borderline resectable pancreatic adenocarcinoma. Jpn J Clin Oncol 2014; 44: 1172-1180 [PMID: 25425728 DOI: 10.1093/jjco/hyu143]
-
(2014)
Jpn J Clin Oncol
, vol.44
, pp. 1172-1180
-
-
Takeda, Y1
Nakamori, S2
Eguchi, H3
Kobayashi, S4
Marubashi, S5
Tanemura, M6
Konishi, K7
Yoshioka, Y8
Umeshita, K9
Mori, M10
Doki, Y11
Nagano, H.12
-
50
-
-
84869133829
-
A phase I/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine (FDR-G) in patients with unresectable pancreatic cancer
-
50 [PMID: 22543215]
-
50 Ben-Josef E, Schipper M, Francis IR, Hadley S, Ten-Haken R, Lawrence T, Normolle D, Simeone DM, Sonnenday C, Abrams R, Leslie W, Khan G, Zalupski MM. A phase I/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine (FDR-G) in patients with unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys 2012; 84: 1166-1171 [PMID: 22543215 DOI: 10.1016/j.ijrobp.2012.02.051]
-
(2012)
Int J Radiat Oncol Biol Phys
, vol.84
, pp. 1166-1171
-
-
Ben-Josef, E1
Schipper, M2
Francis, IR3
Hadley, S4
Ten-Haken, R5
Lawrence, T6
Normolle, D7
Simeone, DM8
Sonnenday, C9
Abrams, R10
Leslie, W11
Khan, G12
Zalupski, MM.13
-
51
-
-
84903163207
-
Participation of the elderly population in clinical trials: barriers and solutions
-
51 [PMID: 24955704]
-
51 Denson AC, Mahipal A. Participation of the elderly population in clinical trials: barriers and solutions. Cancer Control 2014; 21: 209-214 [PMID: 24955704]
-
(2014)
Cancer Control
, vol.21
, pp. 209-214
-
-
Denson, AC1
Mahipal, A.2
-
52
-
-
62249176551
-
DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer
-
52 [PMID: 19273710]
-
52 Iacobuzio-Donahue CA, Fu B, Yachida S, Luo M, Abe H, Henderson CM, Vilardell F, Wang Z, Keller JW, Banerjee P, Herman JM, Cameron JL, Yeo CJ, Halushka MK, Eshleman JR, Raben M, Klein AP, Hruban RH, Hidalgo M, Laheru D. DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. J Clin Oncol 2009; 27: 1806-1813 [PMID: 19273710 DOI: 10.1200/JCO.2008.17.7188]
-
(2009)
J Clin Oncol
, vol.27
, pp. 1806-1813
-
-
Iacobuzio-Donahue, CA1
Fu, B2
Yachida, S3
Luo, M4
Abe, H5
Henderson, CM6
Vilardell, F7
Wang, Z8
Keller, JW9
Banerjee, P10
Herman, JM11
Cameron, JL12
Yeo, CJ13
Halushka, MK14
Eshleman, JR15
Raben, M16
Klein, AP17
Hruban, RH18
Hidalgo, M19
Laheru, D.20
more..
-
53
-
-
12144288560
-
Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer
-
53 [PMID: 15001240]
-
53 Koong AC, Le QT, Ho A, Fong B, Fisher G, Cho C, Ford J, Poen J, Gibbs IC, Mehta VK, Kee S, Trueblood W, Yang G, Bastidas JA. Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2004; 58: 1017-1021 [PMID: 15001240 DOI: 10.1016/j.ijrobp.2003.11.004]
-
(2004)
Int J Radiat Oncol Biol Phys
, vol.58
, pp. 1017-1021
-
-
Koong, AC1
Le, QT2
Ho, A3
Fong, B4
Fisher, G5
Cho, C6
Ford, J7
Poen, J8
Gibbs, IC9
Mehta, VK10
Kee, S11
Trueblood, W12
Yang, G13
Bastidas, JA.14
-
54
-
-
79961127998
-
Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancer
-
54 [PMID: 21549517]
-
54 Schellenberg D, Kim J, Christman-Skieller C, Chun CL, Columbo LA, Ford JM, Fisher GA, Kunz PL, Van Dam J, Quon A, Desser TS, Norton J, Hsu A, Maxim PG, Xing L, Goodman KA, Chang DT, Koong AC. Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2011; 81: 181-188 [PMID: 21549517 DOI: 10.1016/j.ijrobp.2010.05.006]
-
(2011)
Int J Radiat Oncol Biol Phys
, vol.81
, pp. 181-188
-
-
Schellenberg, D1
Kim, J2
Christman-Skieller, C3
Chun, CL4
Columbo, LA5
Ford, JM6
Fisher, GA7
Kunz, PL8
Van Dam, J9
Quon, A10
Desser, TS11
Norton, J12
Hsu, A13
Maxim, PG14
Xing, L15
Goodman, KA16
Chang, DT17
Koong, AC.18
-
55
-
-
80255131310
-
Induction gemcitabine and stereotactic body radiotherapy for locally advanced nonmetastatic pancreas cancer
-
55 [PMID: 21658854]
-
55 Mahadevan A, Miksad R, Goldstein M, Sullivan R, Bullock A, Buchbinder E, Pleskow D, Sawhney M, Kent T, Vollmer C, Callery M. Induction gemcitabine and stereotactic body radiotherapy for locally advanced nonmetastatic pancreas cancer. Int J Radiat Oncol Biol Phys 2011; 81: e615-e622 [PMID: 21658854 DOI: 10.1016/ j.ijrobp.2011.04.045]
-
(2011)
Int J Radiat Oncol Biol Phys
, vol.81
, pp. e615-e622
-
-
Mahadevan, A1
Miksad, R2
Goldstein, M3
Sullivan, R4
Bullock, A5
Buchbinder, E6
Pleskow, D7
Sawhney, M8
Kent, T9
Vollmer, C10
Callery, M.11
-
56
-
-
79951680957
-
Stereotactic body radiotherapy in the treatment of advanced adenocarcinoma of the pancreas
-
56 [PMID: 20308870]
-
56 Rwigema JC, Parikh SD, Heron DE, Howell M, Zeh H, Moser AJ, Bahary N, Quinn A, Burton SA. Stereotactic body radiotherapy in the treatment of advanced adenocarcinoma of the pancreas. Am J Clin Oncol 2011; 34: 63-69 [PMID: 20308870 DOI: 10.1097/ COC.0b013e3181d270b4]
-
(2011)
Am J Clin Oncol
, vol.34
, pp. 63-69
-
-
Rwigema, JC1
Parikh, SD2
Heron, DE3
Howell, M4
Zeh, H5
Moser, AJ6
Bahary, N7
Quinn, A8
Burton, SA.9
-
57
-
-
77957017958
-
Image-guided stereotactic radiosurgery for locally advanced pancreatic adenocarcinoma results of first 85 patients
-
57 [PMID: 20839073]
-
57 Didolkar MS, Coleman CW, Brenner MJ, Chu KU, Olexa N, Stanwyck E, Yu A, Neerchal N, Rabinowitz S. Image-guided stereotactic radiosurgery for locally advanced pancreatic adenocarcinoma results of first 85 patients. J Gastrointest Surg 2010; 14: 1547-1559 [PMID: 20839073 DOI: 10.1007/s11605-010-1323-7]
-
(2010)
J Gastrointest Surg
, vol.14
, pp. 1547-1559
-
-
Didolkar, MS1
Coleman, CW2
Brenner, MJ3
Chu, KU4
Olexa, N5
Stanwyck, E6
Yu, A7
Neerchal, N8
Rabinowitz, S.9
-
58
-
-
84925356628
-
Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma
-
58 [PMID: 25538019]
-
58 Herman JM, Chang DT, Goodman KA, Dholakia AS, Raman SP, Hacker-Prietz A, Iacobuzio-Donahue CA, Griffith ME, Pawlik TM, Pai JS, O’Reilly E, Fisher GA, Wild AT, Rosati LM, Zheng L, Wolfgang CL, Laheru DA, Columbo LA, Sugar EA, Koong AC. Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma. Cancer 2015; 121: 1128-1137 [PMID: 25538019 DOI: 10.1002/cncr.29161]
-
(2015)
Cancer
, vol.121
, pp. 1128-1137
-
-
Herman, JM1
Chang, DT2
Goodman, KA3
Dholakia, AS4
Raman, SP5
Hacker-Prietz, A6
Iacobuzio-Donahue, CA7
Griffith, ME8
Pawlik, TM9
Pai, JS10
O’Reilly, E11
Fisher, GA12
Wild, AT13
Rosati, LM14
Zheng, L15
Wolfgang, CL16
Laheru, DA17
Columbo, LA18
Sugar, EA19
Koong, AC.20
more..
-
59
-
-
84880635783
-
Stereotactic body radiation therapy for locally advanced and borderline resectable pancreatic cancer is effective and well tolerated
-
59 [PMID: 23562768]
-
59 Chuong MD, Springett GM, Freilich JM, Park CK, Weber JM, Mellon EA, Hodul PJ, Malafa MP, Meredith KL, Hoffe SE, Shridhar R. Stereotactic body radiation therapy for locally advanced and borderline resectable pancreatic cancer is effective and well tolerated. Int J Radiat Oncol Biol Phys 2013; 86: 516-522 [PMID: 23562768 DOI: 10.1016/j.ijrobp.2013.02.022]
-
(2013)
Int J Radiat Oncol Biol Phys
, vol.86
, pp. 516-522
-
-
Chuong, MD1
Springett, GM2
Freilich, JM3
Park, CK4
Weber, JM5
Mellon, EA6
Hodul, PJ7
Malafa, MP8
Meredith, KL9
Hoffe, SE10
Shridhar, R.11
-
60
-
-
84903268334
-
A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine followed by early surgery for resectable pancreatic ductal adenocarcinoma
-
60 [PMID: 24867540]
-
60 Hong TS, Ryan DP, Borger DR, Blaszkowsky LS, Yeap BY, Ancukiewicz M, Deshpande V, Shinagare S, Wo JY, Boucher Y, Wadlow RC, Kwak EL, Allen JN, Clark JW, Zhu AX, Ferrone CR, Mamon HJ, Adams J, Winrich B, Grillo T, Jain RK, DeLaney TF, Fernandez-del Castillo C, Duda DG. A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine followed by early surgery for resectable pancreatic ductal adenocarcinoma. Int J Radiat Oncol Biol Phys 2014; 89: 830-838 [PMID: 24867540 DOI: 10.1016/ j.ijrobp.2014.03.034]
-
(2014)
Int J Radiat Oncol Biol Phys
, vol.89
, pp. 830-838
-
-
Hong, TS1
Ryan, DP2
Borger, DR3
Blaszkowsky, LS4
Yeap, BY5
Ancukiewicz, M6
Deshpande, V7
Shinagare, S8
Wo, JY9
Boucher, Y10
Wadlow, RC11
Kwak, EL12
Allen, JN13
Clark, JW14
Zhu, AX15
Ferrone, CR16
Mamon, HJ17
Adams, J18
Winrich, B19
Grillo, T20
Jain, RK21
DeLaney, TF22
Fernandez-del Castillo, C23
Duda, DG.24
more..
-
61
-
-
67650954456
-
Dose escalation with proton or photon radiation treatment for pancreatic cancer
-
61 [PMID: 19454367]
-
61 Bouchard M, Amos RA, Briere TM, Beddar S, Crane CH. Dose escalation with proton or photon radiation treatment for pancreatic cancer. Radiother Oncol 2009; 92: 238-243 [PMID: 19454367 DOI: 10.1016/j.radonc.2009.04.015]
-
(2009)
Radiother Oncol
, vol.92
, pp. 238-243
-
-
Bouchard, M1
Amos, RA2
Briere, TM3
Beddar, S4
Crane, CH.5
-
62
-
-
84904651715
-
A dosimetric comparison of proton and photon therapy in unresectable cancers of the head of pancreas
-
62 [PMID: 25086521]
-
62 Thompson RF, Mayekar SU, Zhai H, Both S, Apisarnthanarax S, Metz JM, Plastaras JP, Ben-Josef E. A dosimetric comparison of proton and photon therapy in unresectable cancers of the head of pancreas. Med Phys 2014; 41: 081711 [PMID: 25086521 DOI: 10.1118/1.4887797]
-
(2014)
Med Phys
, vol.41
, pp. 081711
-
-
Thompson, RF1
Mayekar, SU2
Zhai, H3
Both, S4
Apisarnthanarax, S5
Metz, JM6
Plastaras, JP7
Ben-Josef, E.8
-
63
-
-
0034329115
-
Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators
-
63 [PMID: 11307091]
-
63 Sohn TA, Yeo CJ, Cameron JL, Koniaris L, Kaushal S, Abrams RA, Sauter PK, Coleman J, Hruban RH, Lillemoe KD. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 2000; 4: 567-579 [PMID: 11307091]
-
(2000)
J Gastrointest Surg
, vol.4
, pp. 567-579
-
-
Sohn, TA1
Yeo, CJ2
Cameron, JL3
Koniaris, L4
Kaushal, S5
Abrams, RA6
Sauter, PK7
Coleman, J8
Hruban, RH9
Lillemoe, KD.10
-
64
-
-
0035212974
-
Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial
-
64 [PMID: 11729382]
-
64 Neoptolemos JP, Stocken DD, Dunn JA, Almond J, Beger HG, Pederzoli P, Bassi C, Dervenis C, Fernandez-Cruz L, Lacaine F, Buckels J, Deakin M, Adab FA, Sutton R, Imrie C, Ihse I, Tihanyi T, Olah A, Pedrazzoli S, Spooner D, Kerr DJ, Friess H, Buchler MW. Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg 2001; 234: 758-768 [PMID: 11729382]
-
(2001)
Ann Surg
, vol.234
, pp. 758-768
-
-
Neoptolemos, JP1
Stocken, DD2
Dunn, JA3
Almond, J4
Beger, HG5
Pederzoli, P6
Bassi, C7
Dervenis, C8
Fernandez-Cruz, L9
Lacaine, F10
Buckels, J11
Deakin, M12
Adab, FA13
Sutton, R14
Imrie, C15
Ihse, I16
Tihanyi, T17
Olah, A18
Pedrazzoli, S19
Spooner, D20
Kerr, DJ21
Friess, H22
Buchler, MW.23
more..
-
65
-
-
33751212765
-
1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience
-
65 ; discussion 1210-1211 [PMID: 17114007]
-
65 Winter JM, Cameron JL, Campbell KA, Arnold MA, Chang DC, Coleman J, Hodgin MB, Sauter PK, Hruban RH, Riall TS, Schulick RD, Choti MA, Lillemoe KD, Yeo CJ. 1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience. J Gastrointest Surg 2006; 10: 1199-1210; discussion 1210-1211 [PMID: 17114007 DOI: 10.1016/j.gassur.2006.08.018]
-
(2006)
J Gastrointest Surg
, vol.10
, pp. 1199-1210
-
-
Winter, JM1
Cameron, JL2
Campbell, KA3
Arnold, MA4
Chang, DC5
Coleman, J6
Hodgin, MB7
Sauter, PK8
Hruban, RH9
Riall, TS10
Schulick, RD11
Choti, MA12
Lillemoe, KD13
Yeo, CJ.14
-
66
-
-
0031426723
-
Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience
-
66 ; discussion 633-636 [PMID: 9193189]
-
66 Yeo CJ, Abrams RA, Grochow LB, Sohn TA, Ord SE, Hruban RH, Zahurak ML, Dooley WC, Coleman J, Sauter PK, Pitt HA, Lillemoe KD, Cameron JL. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. Ann Surg 1997; 225: 621-633; discussion 633-636 [PMID: 9193189]
-
(1997)
Ann Surg
, vol.225
, pp. 621-633
-
-
Yeo, CJ1
Abrams, RA2
Grochow, LB3
Sohn, TA4
Ord, SE5
Hruban, RH6
Zahurak, ML7
Dooley, WC8
Coleman, J9
Sauter, PK10
Pitt, HA11
Lillemoe, KD12
Cameron, JL.13
-
67
-
-
0031918491
-
DNA content and other factors associated with ten-year survival after resection of pancreatic carcinoma
-
67 [PMID: 9530884]
-
67 Allison DC, Piantadosi S, Hruban RH, Dooley WC, Fishman EK, Yeo CJ, Lillemoe KD, Pitt HA, Lin P, Cameron JL. DNA content and other factors associated with ten-year survival after resection of pancreatic carcinoma. J Surg Oncol 1998; 67: 151-159 [PMID: 9530884]
-
(1998)
J Surg Oncol
, vol.67
, pp. 151-159
-
-
Allison, DC1
Piantadosi, S2
Hruban, RH3
Dooley, WC4
Fishman, EK5
Yeo, CJ6
Lillemoe, KD7
Pitt, HA8
Lin, P9
Cameron, JL.10
-
68
-
-
84901455120
-
Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS)
-
68 [PMID: 24856119]
-
68 Bockhorn M, Uzunoglu FG, Adham M, Imrie C, Milicevic M, Sandberg AA, Asbun HJ, Bassi C, Buchler M, Charnley RM, Conlon K, Cruz LF, Dervenis C, Fingerhutt A, Friess H, Gouma DJ, Hartwig W, Lillemoe KD, Montorsi M, Neoptolemos JP, Shrikhande SV, Takaori K, Traverso W, Vashist YK, Vollmer C, Yeo CJ, Izbicki JR. Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 2014; 155: 977-988 [PMID: 24856119 DOI: 10.1016/j.surg.2014.02.001]
-
(2014)
Surgery
, vol.155
, pp. 977-988
-
-
Bockhorn, M1
Uzunoglu, FG2
Adham, M3
Imrie, C4
Milicevic, M5
Sandberg, AA6
Asbun, HJ7
Bassi, C8
Buchler, M9
Charnley, RM10
Conlon, K11
Cruz, LF12
Dervenis, C13
Fingerhutt, A14
Friess, H15
Gouma, DJ16
Hartwig, W17
Lillemoe, KD18
Montorsi, M19
Neoptolemos, JP20
Shrikhande, SV21
Takaori, K22
Traverso, W23
Vashist, YK24
Vollmer, C25
Yeo, CJ26
Izbicki, JR.27
more..
-
69
-
-
77953027002
-
Positive mobilization margins alone do not influence survival following pancreatico-duodenectomy for pancreatic ductal adenocarcinoma
-
69 [PMID: 20485150]
-
69 Jamieson NB, Foulis AK, Oien KA, Going JJ, Glen P, Dickson EJ, Imrie CW, McKay CJ, Carter R. Positive mobilization margins alone do not influence survival following pancreatico-duodenectomy for pancreatic ductal adenocarcinoma. Ann Surg 2010; 251: 1003-1010 [PMID: 20485150 DOI: 10.1097/SLA.0b013e3181d77369]
-
(2010)
Ann Surg
, vol.251
, pp. 1003-1010
-
-
Jamieson, NB1
Foulis, AK2
Oien, KA3
Going, JJ4
Glen, P5
Dickson, EJ6
Imrie, CW7
McKay, CJ8
Carter, R.9
-
70
-
-
70449106271
-
Neoadjuvant chemoradiation and pancreaticoduodenectomy for initially locally advanced head pancreatic adenocarcinoma
-
70 [PMID: 19576722]
-
70 Turrini O, Viret F, Moureau-Zabotto L, Guiramand J, Moutardier V, Lelong B, Giovannini M, Delpero JR. Neoadjuvant chemoradiation and pancreaticoduodenectomy for initially locally advanced head pancreatic adenocarcinoma. Eur J Surg Oncol 2009; 35: 1306-1311 [PMID: 19576722 DOI: 10.1016/j.ejso.2009.06.005]
-
(2009)
Eur J Surg Oncol
, vol.35
, pp. 1306-1311
-
-
Turrini, O1
Viret, F2
Moureau-Zabotto, L3
Guiramand, J4
Moutardier, V5
Lelong, B6
Giovannini, M7
Delpero, JR.8
-
71
-
-
78049462882
-
Defining venous involvement in borderline resectable pancreatic cancer
-
71 [PMID: 20725860]
-
71 Chun YS, Milestone BN, Watson JC, Cohen SJ, Burtness B, Engstrom PF, Haluszka O, Tokar JL, Hall MJ, Denlinger CS, Astsaturov I, Hoffman JP. Defining venous involvement in borderline resectable pancreatic cancer. Ann Surg Oncol 2010; 17: 2832-2838 [PMID: 20725860 DOI: 10.1245/s10434-010-1284-9]
-
(2010)
Ann Surg Oncol
, vol.17
, pp. 2832-2838
-
-
Chun, YS1
Milestone, BN2
Watson, JC3
Cohen, SJ4
Burtness, B5
Engstrom, PF6
Haluszka, O7
Tokar, JL8
Hall, MJ9
Denlinger, CS10
Astsaturov, I11
Hoffman, JP.12
|